Barclays »

Spruce Biosciences shares owned by Barclays

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 674 54.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Spruce Biosciences

AIGH Capital Management
OrbiMed Advisors
BlackRock
Millennium Management
Ikarian Capital
Vanguard Capital Management
Alyeska Investment Group
Geode Capital Management
ADAR1 Capital Management
Cable Car Capital
Citadel Advisors
Boothbay Fund Management
Stempoint Capital
Eversept Partners
Carlyle

View all funds holding Spruce Biosciences